Abstract:Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): M.I.U.R. PRIN 2017 to E.C and ECRF to L.S. Introduction Ivabradine (Iva), Zatebradine (Zat) and ZD7288 (ZD) are blockers of Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) channels, which play definite electrophysiological functions in cardiac pacemakers, working cardiomyocytes, peripheral and central neurons [1]. Among them, Iva is in clinical use as bradycardic agent for uncontrolled angina and heart failure with reduced ejection fraction. Accumulating evidence suggests Iva may have a more complex pharmacological profile, including targets different from HCN channels [2, 3]. Reports on experimental atrial fibrillation, detrusor contraction and bladder overactivity [4] led us to hypothesize that muscarinic receptors (mAChRs) may represent still unexplored targets of Iva and analogues. Present study was designed to identify the effect of Iva on acetylcholine-gated inward-rectifier K+-current (IKACh), the main effector of atrial mAChRs, and to assess whether Iva and analogues interact directly with human atrial and recombinant mAChRs. Methods Patch-clamp recordings were performed on human atrial myocytes (hAMs) isolated from atrial appendages of patients in sinus rhythm. Competition and kinetic radioligand binding assays were performed on hAM preparations and on mAChR(1,2,3) expressed in heterologous systems. Results Patch-clamp recordings on hAMs demonstrated Iva is able to suppress IKAch similarly to atropine, thus suggesting a functional antagonism of Iva on atrial mAChRs. Competition binding assays on hAM membranes revealed Iva, Zat and ZD bind to mAChRs with affinity values close to those of muscarinic ligands carbachol (Cch) and gallamine (Gal). Competition binding assays on recombinant mAChR(1,2,3), which are functionally relevant in hAMs, showed all blockers are ligands for each single mAChR type with affinity values close to those of CCh and Gal. Finally, using dissociation binding assays on mAChR(2) lacking the allosteric binding site, we showed Iva and Zat behave as allosteric ligands with affinity values similar to Gal. Doking studies confirmed Iva and Zat, but not ZD, have the structural requirements necessary to interact with the allosteric and the orthosteric site of mAChR(2). Conclusions This study demonstrates Iva directly interacts with mAChR expressed in hAMs, showing antimuscarinic activity on IKAch. This property is likely dependent on a double interaction of Iva with the orthosteric and the allosteric site of mAChR(2). Zat, but not ZD, shows similar binding properties compared to Iva. Our results identify a novel pharmacological target for Iva and analogues in human atria, which may have important consequences for the function of the healthy and diseased atrium.

Zacopride stimulates 5-HT4 serotonin receptors in the human atrium

Mosapride stimulates human 5-HT4-serotonin receptors in the heart

Zacopride Exerts an Antiarrhythmic Effect by Specifically Stimulating the Cardiac Inward Rectifier Potassium Current in Rabbits: Exploration of a New Antiarrhythmic Strategy

Tegaserod Stimulates 5-HT4 Serotonin Receptors in the Isolated Human Atrium

Effect of four 5-hydroxytryptamine type 4 receptor agonists on rat cardiac Iκ1 channels and proarrhythmic risk stratification

Clozapine is a functional antagonist at cardiac human H2-histamine receptors

Ergotamine Stimulates Human 5-HT4-Serotonin Receptors and Human H2-Histamine Receptors in the Heart

An Aqueous Extract of Zanthoxylum Schinifolium Has A Positive Inotropic Effect in Beating Rabbit Atria

Pharmacological and physiological assessment of serotonin formation and degradation in isolated preparations from mouse and human hearts

Blockers of Hyperpolarization-activated Cyclic Nucleotide-gated channels exhibit antimuscarinic properties in human atrial cardiomyocytes

Studies on the mechanisms of action of MR33317

5-HT4 Receptor Activation Facilitates Recovery from Synaptic Rundown and Increases Transmitter Release from Single Varicosities of Myenteric Neurons.

Aqueous Extract of Zanthoxylum Schinifolium Elicits Contractile and Secretory Responses Via Β1-Adrenoceptor Activation in Beating Rabbit Atria

Design, Synthesis, and Negative Inotropic Evaluation of 4‐phenyl‐1h‐1,2,4‐triazol‐5(4h)‐one Derivatives Containing Triazole or Piperazine Moieties

Opposite Contractile Effects of Amphetamine-Related Hallucinogenic Drugs in the Isolated Human Atrium

Contractile Effects of Amphetamine, Pseudoephedrine, Nor-pseudoephedrine (Cathine), and Cathinone on Atrial Preparations of Mice and Humans

Contractile Effects of Semaglutide in the Human Atrium

Positive Inotropic Effect of PHR0007 (2-(4-(4-(benzyloxy)-3-methoxybenzyl)piperazin-1-)-n-(1-methyl-4,5-dihydro[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamide) on Atrial Dynamics in Beating Rabbit Atria.

Ontogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT(4) receptors

Blockade of Voltage‐Gated K+ Channels in Rabbit Coronary Arterial Smooth Muscle Cells by the Antipsychotic Drug Zotepine

Synthesis and In-Vitro Inotropic Evaluation of 2-(4-substitutedbenzyl-1,4-diazepan-1-yl)-n-(4,5-dihydro-1-phenyl-[1,2,4 ]Triazolo[4,3-A]quinolin-7-yl)acetamides